ALLERGAN INCInsider Trading & SEC Form 4 Analysis
Institutional analysis of internal capital flows based on SEC Form 4 filings.
+$0
Buys minus sales2017.05.17
Latest Form 41
Reporting entitiesNo buyer detected
No open-market buysNo seller detected
No open-market salesAutomated_Intelligence_Report :: AGN
Algorithmic analysis of recent insider trading activity for AGN reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 1 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $0.00M.
Market dynamics show a positive net capital flow of $0.00M when isolating open-market purchases versus open-market sales. The trading volume is heavily weighted towards open-market executions, providing a clearer signal of insider conviction regarding current valuation levels compared to option-based equity grants.
From a microstructural perspective, the activity is distributed among minor technical trades without a single overwhelming directional catalyst. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of AGN.
$0.00M
USD NOMINAL VALUE1
UNIQUE C-SUITE ENTITIES2017.05.17
ISO_8601 FORMATAutomated_Queries :: Frequently Asked Questions
>How many corporate insiders are active in AGN?
Our dataset currently tracks 1 distinct insiders with reported transactions for AGN in the active reporting window.
>Is insider buying outweighing selling at AGN?
Open-market buying volume ($0.00M) currently exceeds selling volume ($0.00M), suggesting net accumulation by insiders.
>Who is currently buying AGN stock?
Our algorithmic tracking of SEC Form 4 filings indicates no significant open-market buying activity by major executives for AGN in the recent reporting period.